MYC and neoplasm: The WNT/β‐catenin pathway, often hyperactive in EC‐CSCs, upregulates stemness markers such as β‐catenin, c‐MYC, NANOG, and OCT4, perpetuating tumor progression (Banz‐Jansen et al. 2022; Giannone et al. 2019).